Drug intelligence / Profile preview

Protselan

Development stage
Unknown
Lead developer
Research Institute for Physical and Chemical Problems of the Belarusian State University
Modality
Small Molecules
Administration
Topical
01

Overview

Protselan is a multi-component topical ointment developed by the Research Institute for Physical Chemical Problems of the Belarusian State University. It is specifically formulated for the treatment of infected wounds, burns, and various dermatological conditions that require a combination of antimicrobial action, local anesthesia, and tissue regeneration. The drug's formulation typically includes dioxidine (a broad-spectrum quinoxaline-derivative antibacterial agent), trimecaine (a local anesthetic), and methyluracil (a pyrimidine derivative that stimulates cellular repair). Protselan is particularly effective during the first phase of the wound healing process, where it provides bactericidal activity against aerobic and anaerobic microorganisms, reduces inflammatory edema, and alleviates local pain while preparing the wound bed for granulation.

Brand names
Protselan
Other names
ПроцеланProtselan ointment
02

Targets

NeuraminidaseDNASCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on Protselan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protselan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call